Investigated for treating COVID-19.
A higher incidence of bleeding has been reported in patients over 60 years of age, especially women.
Contra-indicated in patients with severe thrombocyopenia.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Calcilean; Calciparin; Caprin; Hep-Flush (Wyeth); Hep-Lock; Hepalean; Heparin-Leo; Heparine; Liquemin; Uniparin; Viaflex (Baxter)
- INDICATIONS: Venous thrombosis, pulmonary embolism, intravascular coagulation, peripheral arterial embolism
- CLASS: Anticoagulant (antithrombotic), Heparinoid
- HALF-LIFE: 2 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acenocoumarol, Aliskiren, Antihistamines, Aspirin, Balsalazide, Bivalirudin, Butabarbital, Ceftobiprole, Dabigatran, Danaparoid, Defibrotide, Desvenlafaxine, Iloprost, Inotersen, Nandrolone, Nicotine, Nitroglycerin, Palifermin, Piperacillin/Tazobactam, Salicylates, Tirofiban, Warfarin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 01/04/2025
